[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100592474":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":17,"locations":10,"responsibleParty":27,"collaborators":10,"id":29,"slug":30,"hasResults":31,"nctId":32,"briefTitle":33,"officialTitle":34,"acronym":35,"eligibilityCriteria":36,"healthyVolunteers":31,"sex":37,"minAge":38,"maxAge":10,"enrollmentInfo":39,"targetDuration":10,"studyType":42,"phases":10,"briefSummary":43,"conditions":44,"keywords":46,"overallStatus":51,"whyStopped":10,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":10},{"fullName":5,"class":6},"University Hospital Schleswig-Holstein","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Patients with steps counted by their smart phone",null,"The purpose is to obtain a patient's mean number of steps per week directly from the patient's smart phone which has a step counter.",[13],{"name":14,"affiliation":15,"role":16},"Dirk Rades, Prof. Dr. med.","University of Lubeck","PRINCIPAL_INVESTIGATOR",[18,23],{"name":14,"role":19,"phone":20,"phoneExt":21,"email":22},"CONTACT","0049-451-500","45400","dirk.rades@uksh.de",{"name":24,"role":19,"phone":20,"phoneExt":25,"email":26},"Sabine Bohnet, Dr. med.","45001","sabine.bohnet@uksh.de",{"type":28,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100592474","physical-activity-during-chemo--andor-immunotherapy-for-lung-cancer-100592474",false,"NCT06993896","Physical Activity During Chemo- and\u002For Immunotherapy for Lung Cancer","Assessment of Physical Activity During Chemo- and\u002For Immunotherapy for Lung Cancer","APACHIE-01","Inclusion Criteria:\n\n1. Histologically proven non-small cell lung cancer\n2. Indication for chemo- and\u002For immunotherapy\n3. Possession of and ability to use a smart phone that includes a step counter\n4. Willingness to wear the smart phone close to the body at any time\n5. Age ≥18 years\n6. Written informed consent\n7. Capacity of the patient to consent\n\nExclusion Criteria:\n\n1. Small-cell lung cancer\n2. Karnofsky performance score \\\u003C60\n3. Thoracic surgery within 3 months prior to chemo- and\u002For immunotherapy\n4. Expected Non-Compliance","ALL","18 Years",{"count":40,"type":41},38,"ESTIMATED","OBSERVATIONAL","The main goal of this trial is to describe the pattern of physical activity in patients with non-small cell lung cancer during chemo- and\u002For immunotherapy, to evaluate potential predictors of those patterns and to assess potential correlations with patient reported outcomes (pain-, distress-, and fatigue scores). To reach this goal, this trial will be first trial in which the mean number of steps per week performed at baseline and during each week of chemo- and or immunotherapy will be collected in a standardized prospective way. The trial is exploratory in nature with the aim to generate scientific hypotheses to be investigated in future clinical trials.",[45],"Lung Cancer (NSCLC)",[47,48,49,50],"lung cancer","chemotherapy","immunotherapy","physical activity","NOT_YET_RECRUITING","2025-05-27",{"date":54,"type":55},"2025-05-29","ACTUAL",{"date":57,"type":41},"2025-06-16",{"date":59,"type":41},"2025-12-31",{"name":5,"class":6}]